Sartorius Stedim Biotech and Refine Technology, a developer and worldwide supplier to the biotech industry of the Alternating Tangential Flow system, will be collaborating on the development of a platform for high-density cell cultivation. More... 30 Jan 2012
The market for stem cell technologies will surge to over USD 700 million in 2012, and given some positive trends could reach over one billion dollars, according to a recent healthcare market report. More... 26 Jan 2012
The coming year is set to witness dramatic growth of biotechnology companies specializing in stem cell research and drug development. More... 25 Jan 2012
Evotec announced a second strategic alliance with Harvard University, this time including Brigham and Women’s Hospital, designed to find and develop new biomarkers and therapies for kidney disease. More... 24 Jan 2012
Bristol-Myers Squibb has acquired experimental hepatitis C virus treatment maker Inhibitex for USD 2 billion in cash, in a transaction that carries a 163% premium. More... 23 Jan 2012
The US anticoagulant market is on the verge of a major transition, shifting from a market dominated by a single injectable anticoagulant to a highly competitive one dominated by first-in-class novel oral anticoagulants. More... 16 Jan 2012
A collaboration brings together the manufacturer of a system for biological image analysis and a large international developer and marketer of dedicated consumable products. More... 19 Dec 2011
BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
